Literature DB >> 15588794

An evaluation of current GERD therapy: a summary and comparison of effectiveness, adverse effects and costs of drugs, surgery and endoscopic therapy.

Peter H Katelaris1.   

Abstract

Mesh:

Substances:

Year:  2004        PMID: 15588794     DOI: 10.1016/j.bpg.2004.06.011

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


× No keyword cloud information.
  6 in total

1.  A randomized controlled trial of laparoscopic Nissen fundoplication versus proton pump inhibitors for the treatment of patients with chronic gastroesophageal reflux disease (GERD): 3-year outcomes.

Authors:  Mehran Anvari; Christopher Allen; John Marshall; David Armstrong; Ron Goeree; Wendy Ungar; Charles Goldsmith
Journal:  Surg Endosc       Date:  2011-04-22       Impact factor: 4.584

Review 2.  Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015.

Authors:  Katsuhiko Iwakiri; Yoshikazu Kinoshita; Yasuki Habu; Tadayuki Oshima; Noriaki Manabe; Yasuhiro Fujiwara; Akihito Nagahara; Osamu Kawamura; Ryuichi Iwakiri; Soji Ozawa; Kiyoshi Ashida; Shuichi Ohara; Hideyuki Kashiwagi; Kyoichi Adachi; Kazuhide Higuchi; Hiroto Miwa; Kazuma Fujimoto; Motoyasu Kusano; Yoshio Hoshihara; Tatsuyuki Kawano; Ken Haruma; Michio Hongo; Kentaro Sugano; Mamoru Watanabe; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2016-06-21       Impact factor: 7.527

3.  Medical, surgical, and endoscopic management of gastroesophageal reflux disease.

Authors:  Deron J Tessier
Journal:  Perm J       Date:  2009

4.  Efficacy and safety of twice-daily rabeprazole maintenance therapy for patients with reflux esophagitis refractory to standard once-daily proton pump inhibitor: the Japan-based EXTEND study.

Authors:  Yoshikazu Kinoshita; Mototsugu Kato; Mitsuhiro Fujishiro; Hironori Masuyama; Ryo Nakata; Hisanori Abe; Shinji Kumagai; Yasushi Fukushima; Yoshiumi Okubo; Seiichiro Hojo; Motoyasu Kusano
Journal:  J Gastroenterol       Date:  2017-11-29       Impact factor: 7.527

5.  Recent effectiveness of proton pump inhibitors for severe reflux esophagitis: the first multicenter prospective study in Japan.

Authors:  Hideki Mizuno; Nobuyuki Matsuhashi; Masahiro Sakaguchi; Syuji Inoue; Koji Nakada; Kazuhide Higuchi; Ken Haruma; Takashi Joh
Journal:  J Clin Biochem Nutr       Date:  2015-10-07       Impact factor: 3.114

6.  Efficacy of DA-5204 (Stillen 2X) for patients with gastroesophageal reflux disease: A randomized, double-blind, placebo-controlled pilot study.

Authors:  Jae Ho Cho; Hyuk Yoon; Cheol Min Shin; Young Soo Park; Nayoung Kim; Dong Ho Lee
Journal:  Medicine (Baltimore)       Date:  2020-10-30       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.